Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute, shared a post on LinkedIn:
“Sarah Cannon Research Institute and SCRI Oncology Partners showing up strong for McKesson Accelerate meeting.
The commitment of this network to research, to advance care for patients through drug development, and to make all this accessible for patients in their OWN communities is truly inspiring.
So much innovation coming. From personalized medicine and trial matching (Genospace, Andrew McKenzie) to changing the way trials are actually delivered (Accelero, Marcy Vallone), it is such an exciting time.
Thank you Devon Dickey Womack, Kirk Kaminsky, Brian Tyler, Dee Anna Smith.”
More posts featuring Erika Hamilton on OncoDaily.
